Silvadene Related Published Studies
Well-designed clinical trials related to Silvadene (Silver Sulfadiazine Topical)
A silver-coated antimicrobial barrier dressing used postoperatively on meshed autografts: a dressing comparison study. [2007.09]
Randomised clinical trial of Hydrofiber dressing with silver versus povidone-iodine gauze in the management of open surgical and traumatic wounds. [2007.03]
Comparison of efficacy of 1% silver sulfadiazine and Acticoat for treatment of partial-thickness burn wounds. [2006.07]
Randomized clinical study of Hydrofiber dressing with silver or silver sulfadiazine in the management of partial-thickness burns. [2006.05]
[Effect of silver nanoparticle dressing on second degree burn wound] [2006.01.01]
The effect of topical application of human milk, ethyl alcohol 96%, and silver sulfadiazine on umbilical cord separation time in newborn infants. [2006.01]
Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial. [2005.10.18]
Second-degree burns: a comparative, multicenter, randomized trial of hyaluronic acid plus silver sulfadiazine vs. silver sulfadiazine alone. [2005.08]
A prospective, randomized trial of Acticoat versus silver sulfadiazine in the treatment of partial-thickness burns: which method is less painful? [2005.07]
Reduction of catheter-related infections in neutropenic patients: a prospective controlled randomized trial using a chlorhexidine and silver sulfadiazine-impregnated central venous catheter. [2005.04]
Prevention of intravascular catheter-related infection with newer chlorhexidine-silver sulfadiazine-coated catheters: a randomized controlled trial. [2004.05]
A randomized controlled trial of silver sulfadiazine, biafine, and saline-soaked gauze in the treatment of superficial partial-thickness burn wounds in pigs. [2004.04]
Evaluation of a triple-lumen central venous heparin-coated catheter versus a catheter coated with chlorhexidine and silver sulfadiazine in critically ill patients. [2004.04]
Topical treatment of partial thickness burns by silver sulfadiazine plus hyaluronic acid compared to silver sulfadiazine alone: a double-blind, clinical study. [2004]
A comparison of topical Phenytoin with Silverex in the treatment of superficial dermal burn wounds. [2002.09]
An open study comparing topical silver sulfadiazine and topical silver sulfadiazine-cerium nitrate in the treatment of moderate and severe burns. [2001.02]
The role of alternative therapy in the management of partial thickness burns of the face--experience with the use of moist exposed burn ointment (MEBO) compared with silver sulphadiazine. [2000.01]
Biobrane versus 1% silver sulfadiazine in second-degree pediatric burns. [2000.01]
Comparative trial of octyl-cyanoacrylate and silver sulfadiazine for the treatment of full-thickness skin wounds. [1999.09]
A prospective randomised clinical and histological study of superficial burn wound healing with honey and silver sulfadiazine. [1998.03]
Influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia. [1998.01.12]
Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: a randomized controlled trial. [1997.10]
Decreased bacterial adherence and biofilm formation on chlorhexidine and silver sulfadiazine-impregnated central venous catheters implanted in swine. [1995.05]
Wound healing in partial-thickness burn wounds treated with collagenase ointment versus silver sulfadiazine cream. [1995.05]
[A comparison between "moist ointment" and 0.25% iodophor, silver sulfadiazine paste and 0.1% rivanol in the treatment of deep II degree burn wounds] [1994.09]
[Finger tip injuries. A comparative study of silver sulfadiazine and fucidin gauze] [1993.11.08]
DuoDERM hydroactive dressing versus silver sulphadiazine/Bactigras in the emergency treatment of partial skin thickness burns. [1992.08]
Randomized trial of meatal care with silver sulfadiazine cream for the prevention of catheter-associated bacteriuria. [1992.01]
Comparison of a hydrocolloid dressing and silver sulfadiazine cream in the outpatient management of second-degree burns. [1990.07]
Outpatient management of partial-thickness burns: Biobrane versus 1% silver sulfadiazine. [1990.02]
Topical silver sulphadiazine--a new drug for ocular keratomycosis. [1988.03]
Well-designed clinical trials possibly related to Silvadene (Silver Sulfadiazine Topical)
Evaluation of Bensal HP for the treatment of diabetic foot ulcers. [2008.10]
Prevention of central venous catheter related infections with chlorhexidine gluconate impregnated wound dressings: a randomized controlled trial. [2008.08.05]
A Liposome Hydrogel With Polyvinyl-Pyrrolidone Iodine in the Local Treatment of Partial-Thickness Burn Wounds. [2007.10]
Accelerating effects of epidermal growth factor on skin lesions of pemphigus vulgaris: a double-blind, randomized, controlled trial. [2007.01]
Accelerating effects of epidermal growth factor on skin lesions of pemphigus vulgaris: a double-blind, randomized, controlled trial. [2007.01]
Efficacy of antiseptic-impregnated catheters on catheter colonization and catheter-related bloodstream infections in patients in an intensive care unit. [2006.02]
Central venous catheter colonization in critically ill patients: a prospective, randomized, controlled study comparing standard with two antiseptic-impregnated catheters. [2005.12]
Treatment of second degree facial burns with allografts--preliminary results. [2005.08]
Management of an acute thermal injury with subatmospheric pressure. [2005.03.24]
Treatment of partial-thickness burns: a prospective, randomized trial using Transcyte. [2004.08]
A randomized, controlled trial of tea tree topical preparations versus a standard topical regimen for the clearance of MRSA colonization. [2004.04]
Comparison of four different dressings on donor site wounds. [2004.03]
Effect of central venous catheter type on infections: a prospective clinical trial. [2003.05]
The relationship between methodological trial quality and the effects of impregnated central venous catheters. [2003.03]
Biobrane improves wound healing in burned children without increased risk of infection. [2000.09]
Evaluation of antiseptic-impregnated central venous catheters for prevention of catheter-related infection in intensive care unit patients. [2000.09]
Antiseptic-bonded central venous catheters and bacterial colonisation. [1999.09]
Octylcyanoacrylate for the treatment of partial-thickness burns in swine: a randomized, controlled experiment. [1999.07]
Safety and efficacy of TransCyte for the treatment of partial-thickness burns. [1999.07]
Decreasing catheter colonization through the use of an antiseptic-impregnated catheter: a continuous quality improvement project. [1999.06]
A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. [1999.01.07]
Prospective, randomized study of the efficacy of Mepitel on children with partial-thickness scalds. [1998.07]
A prospective randomized trial of an antibiotic- and antiseptic-coated central venous catheter in the prevention of catheter-related infections. [1997.12]
Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial. [1997.08.15]
Antiseptic-impregnated central venous catheters reduce the incidence of bacterial colonization and associated infection in immunocompromised transplant patients. [1997.07]
Failure of antiseptic bonding to prevent central venous catheter-related infection and sepsis. [1996.08]
Central venous catheters revisited--infection rates and an assessment of the new Fibrin Analysing System brush. [1996.06]
Accelerated healing and reduced need for grafting in pediatric patients with burns treated with arginine-glycine-aspartic acid peptide matrix. RGD Study Group. [1995.07]
Prospective evaluation of topical antibiotics for preventing infections in uncomplicated soft-tissue wounds repaired in the ED. [1995.01]
European comparative clinical study of Inerpan: a new wound dressing in treatment of partial skin thickness burns. [1992.10]
A prospective randomized evaluator-blinded trial of two potential wound healing agents for the treatment of venous stasis ulcers. [1992.08]
The use of GORE-TEX bags for hand burns. [1991.04]
Clinical studies on growth factors in pressure sores: preliminary report. [1991]
Ambulatory management of burns in children. [1989.08]
Enhancement of wound healing by topical treatment with epidermal growth factor. [1989.07.13]
Randomized study of six umbilical cord care regimens. Comparing length of attachment, microbial control, and satisfaction. [1988.03]
Moisture-vapour-permeable film as an outpatient burn dressing. [1988.02]
Other research related to Silvadene (Silver Sulfadiazine Topical)
Antimicrobial chlorhexidine/silver sulfadiazine-coated central venous catheters versus those uncoated in patients undergoing allogeneic stem cell transplantation. [2008.05.01]
Argyria attributed to silvadene application in a patient with dystrophic epidermolysis bullosa. [2008.04.15]
Phase 2 study of silver leaf dressing for treatment of radiation-induced dermatitis in patients receiving radiotherapy to the head and neck. [2008.02]
[Local therapy of grade IIa burns : Efficacy and tolerability of a new hydrosome wound gel for the local treatment of grade IIa burns as compared with silver sulfadiazine ointment.] [2007.11]
Comparison of topical iodine and silver sulfadiazine as therapies against sulfur mustard burns in a pig model. [2007.11]
Effect of chlorhexidine/silver sulfadiazine-impregnated central venous catheters in an intensive care unit with a low blood stream infection rate after implementation of an educational program: a before-after trial. [2007.08]
A silver impregnated antimicrobial dressing reduces hospital length of stay for pediatric patients with burns. [2007.05]
Assessment and management of wound infection: the role of silver. [2007.03]
Silver treatments for leg ulcers: a systematic review. [2007.03]
Effect of silver on burn wound infection control and healing: review of the literature. [2007.03]
Comparison between Alpha and silver sulfadiazine ointments in treatment of Pseudomonas infections in 3rd degree burns. [2007.02]
A silver-impregnated antimicrobial dressing reduces hospital costs for pediatric burn patients. [2007.01]
Best evidence topic report. Silver sulphadiazine cream in burns. [2006.12]
Silver as biocides in burn and wound dressings and bacterial resistance to silver compounds. [2006.07]
Design and delivery of silver sulfadiazine from alginate microspheres-impregnated collagen scaffold. [2006.05]
Healing at home: Comparing cohorts of children with medium-sized burns treated as outpatients with in-hospital applied Acticoat to those children treated as inpatients with silver sulfadiazine. [2006.03]
[Multi-center clinical study of acticoat (nanocrystalline silver dressing) for the management of residual burn wounds] [2006.02]
Application of cerium nitrate-silver sulphadiazine allows for postponement of excision and grafting. [2006.02]
Chlorhexidine and silver-sulfadiazine coated central venous catheters in haematological patients--a double-blind, randomised, prospective, controlled trial. [2005.12]
[Topical silver sulfadiazine-induced acute renal failure] [2005.11]
Comparison of silver-coated dressing (Acticoat), chlorhexidine acetate 0.5% (Bactigrass), and silver sulfadiazine 1% (Silverdin) for topical antibacterial effect in Pseudomonas aeruginosa-contaminated, full-skin thickness burn wounds in rats. [2005.09]
A silver coated dressing reduces the incidence of early burn wound cellulitis and associated costs of inpatient treatment: comparative patient care audits. [2005.08]
[Microbiological evaluation of 1% silver sulfadiazine dressings] [2005.07]
IPM/DOSS/water microemulsions as reactors for silver sulfadiazine nanocrystal synthesis. [2005.06]
Therapeutic efficacy of three silver dressings in an infected animal model. [2005.01]
Oxacillin- and mupirocin-resistant Staphylococcus aureus: in vitro activity of silver sulphadiazine and cerium nitrate in hospital strains. [2004.10]
[Hydro-cellular dressing and silver sulfadiazine. Evaluation of its combination in the treatment of infected skin ulcers] [2004.07]
A silver sulphadiazine-impregnated lipidocolloid wound dressing to treat second-degree burns. [2004.04]
How safe is silver in wound care? [2004.04]
A review of the use of silver in wound care: facts and fallacies. [2004.03]
Retardation of wound healing by silver sulfadiazine is reversed by Aloe vera and nystatin. [2003.12]
Effect of topically applied silver sulfadiazine on fibroblast cell proliferation and biomechanical properties of the wound. [2003.10]
Scar-localized argyria secondary to silver sulfadiazine cream. [2003.10]
|
